Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).

Fialová D, Laffon B, Marinković V, Tasić L, Doro P, Sόos G, Mota J, Dogan S, Brkić J, Teixeira JP, Valdiglesias V, Costa S; EUROAGEISM H2020 project and WG1b group “Healthy clinical strategies for healthy aging” of the EU COST Action IS 1402.

Eur J Clin Pharmacol. 2019 Apr;75(4):451-466. doi: 10.1007/s00228-018-2603-5. Epub 2019 Jan 4. Review.

PMID:
30610276
2.

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

Fucikova J, Podrazil M, Jarolim L, Bilkova P, Hensler M, Becht E, Gasova Z, Klouckova J, Kayserova J, Horvath R, Fialova A, Vavrova K, Sochorova K, Rozkova D, Spisek R, Bartunkova J.

Cancer Immunol Immunother. 2018 Jan;67(1):89-100. doi: 10.1007/s00262-017-2068-x. Epub 2017 Sep 25.

PMID:
28948333
3.

Risk factors for cardiovascular diseases in physicians.

Nakládalová M, Sovová E, Ivanová K, Kaletová M, Lukl J, Fialová J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):293-5.

Supplemental Content

Loading ...
Support Center